Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Dec 31, 2025 | (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 203.75%638.44K | 190.43%715.94K | 229.93%493.84K | 427.08%954.81K | 628.06%348.44K | 203.76%210.19K | 547.19%246.51K | 475.50%149.68K | 181.15K | 47.86K |
| Operating revenue | 203.75%638.44K | 190.43%715.94K | 229.93%493.84K | 427.08%954.81K | 628.06%348.44K | 203.76%210.19K | 547.19%246.51K | 475.50%149.68K | --181.15K | --47.86K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 21.58%860.29K | -4.48%586.86K | 38.92%640.33K | 24.81%2.54M | 218.25%752.62K | 4.00%707.61K | 2.57%614.39K | -10.61%460.95K | 58.78%2.03M | 236.49K |
| Selling and administrative expenses | 21.58%860.29K | -4.48%586.86K | 38.92%640.33K | 24.81%2.54M | 218.25%752.62K | 4.00%707.61K | 2.57%614.39K | -10.61%460.95K | 103.74%2.03M | --236.49K |
| -General and administrative expense | 21.58%860.29K | -4.48%586.86K | 38.92%640.33K | 24.81%2.54M | 218.25%752.62K | 4.00%707.61K | 2.57%614.39K | -10.61%460.95K | 103.74%2.03M | --236.49K |
| Operating profit | 55.40%-221.84K | 135.09%129.08K | 52.94%-146.49K | 14.57%-1.58M | -114.28%-404.18K | 18.62%-497.43K | 34.41%-367.88K | 36.43%-311.27K | -44.62%-1.85M | -188.63K |
| Net non-operating interest income (expenses) | -1,346.20%-12.62K | -17.89%436 | -411.56%-1.16K | -44.64%2.16K | -53.48%247 | 155.81%1.01K | -45.82%531 | -81.40%372 | -67.24%3.91K | 531 |
| Non-operating interest income | -65.84%346 | -23.91%436 | -15.79%432 | -39.95%2.35K | -53.48%247 | 155.81%1.01K | -41.53%573 | -74.35%513 | -67.24%3.91K | --531 |
| Non-operating interest expense | --12.97K | --0 | 1,028.37%1.59K | --183 | --0 | --0 | --42 | --141 | --0 | --0 |
| Other net income (expenses) | ||||||||||
| Income before tax | 52.77%-234.47K | 135.26%129.52K | 52.51%-147.65K | 14.51%-1.58M | -114.75%-403.93K | 18.73%-496.41K | 34.39%-367.35K | 36.25%-310.9K | -45.68%-1.85M | -188.1K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 52.77%-234.47K | 135.26%129.52K | 52.51%-147.65K | 14.51%-1.58M | -114.75%-403.93K | 18.73%-496.41K | 34.39%-367.35K | 36.25%-310.9K | -45.68%-1.85M | -188.1K |
| Net income continuous operations | 52.77%-234.47K | 135.26%129.52K | 52.51%-147.65K | 14.51%-1.58M | -114.75%-403.93K | 18.73%-496.41K | 34.39%-367.35K | 36.25%-310.9K | -45.68%-1.85M | ---188.1K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 52.77%-234.47K | 135.26%129.52K | 52.51%-147.65K | 14.51%-1.58M | -114.75%-403.93K | 18.73%-496.41K | 34.39%-367.35K | 36.25%-310.9K | -45.68%-1.85M | -188.1K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 52.77%-234.47K | 135.26%129.52K | 52.51%-147.65K | 14.51%-1.58M | -114.75%-403.93K | 18.73%-496.41K | 34.39%-367.35K | 36.25%-310.9K | -45.68%-1.85M | -188.1K |
| Diluted earnings per share | 53.40%-0.0093 | 193.20%0.0093 | 0.00%-0.01 | 14.29%-0.06 | -100.00%-0.02 | 0.00%-0.02 | 50.00%-0.01 | 50.00%-0.01 | 0.00%-0.07 | -0.01 |
| Basic earnings per share | 53.40%-0.0093 | 193.20%0.0093 | 0.00%-0.01 | 14.29%-0.06 | -100.00%-0.02 | 0.00%-0.02 | 50.00%-0.01 | 50.00%-0.01 | 0.00%-0.07 | -0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.